홈MCP워크벤치Skills
홈워크벤치알림마이페이지
Huagongshe 오픈 프로젝트:[email protected]AI 접속: llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.7.8
  1. 홈
  2. /화합물

N,N'-디니트로소피페라진

N,N'-Dinitrosopiperazine

HCID 8819
노트반응
기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트
부분 구조 검색유사 구조 찾기

기본 정보

CAS
140-79-4
표준 SMILES
O=NN1CCN(N=O)CC1
InChIKey
WNSYEWGYAFFSSQ-UHFFFAOYSA-N
분자식
C4.H8.N4.O2
평균 분자량
144.13 g/mol
단동위원소 질량
144.06472551

개요

Carcinogen is any chemical, biological or physical agents that increase the risk of neoplasms in humans or animals. Carcinogens include natural or synthesized compounds, certain viruses, and various sources of radiation. A carcinogen may directly alter the genetic material of cells (genotoxic), thereby initiating or promoting the process of malignant transformation; it also may induce cancers by mechanisms that do not involve a direct alteration of cellular genetic material (non-genotoxic). (NCI04)

이름 및 식별자

우선 이름
N,N'-Dinitrosopiperazine
IUPAC
1,4-dinitrosopiperazine
현지명
N,N'-디니트로소피페라진
영어명
N,N'-DINITROSOPIPERAZINE
분자식
C4H8N4O2
분자량
144.13

이름 및 동의어

1,4-DINITROSOPIPERAZINE140-79-4N,N'-DinitrosopiperazineDinitrosopiperazineDinitrosopiperazinN-DinitrosopiperazineDNPZUSAF DO-36NSC 339DTXSID0020527NSC-339GU48C6581I
이름 더 보기
N,N'-디니트로소피페라진nsc339usafdo-361,4-DinitroanilineTIMTEC-BB SBB008187
DTXCID00527RefChem:73326205-434-6Piperazine, 1,4-dinitroso-CarcinogenRifapentine Impurity 2NN'-Dinitrosopiperazine1,4-Dinitroso-piperazine

데이터베이스 식별자

CAS
140-79-4
PubChem CID
8819
DTXSID
DTXSID0020527
ChEMBL
CHEMBL1332
UNII
GU48C6581I
EC Number
205-434-6
Nikkaji
J2.951C

물성

구조 계산 물성

XLogP
-0.8
극성 표면적
65.3 Ų
수소 결합 공여자 수
0
수소 결합 수용자 수
6
회전 가능 결합 수
0
무거운 원자 수
10
형식 전하
0
복잡도
115

실험 및 물리화학적 성질

Chemical ClassesNitrogen Compounds -> Nitrosamines
SpringerMaterials Properties15N nuclear magnetic resonance spectrum
LogP · 2건

-0.85

-0.85

Color/FormPALE YELLOW PLATES FROM WATER
SolubilitySLIGHTLY SOL IN WATER, ACETONE; VERY SOL IN HOT ALCOHOL
Melting Point · 2건

158 °C

158 °C

Vapor Pressure0.00019 [mmHg]
Physical DescriptionPale yellow solid; [HSDB]

물리화학적 성질

녹는점
208 · 208-210°C
끓는 점
262.72 °C · 262.72°C (rough estimate)
밀도
1.4165 · 1.4165 (rough estimate)
굴절률
1.85 · 1.8500 (estimate)

안전 및 규제

안전 정보는 참고용이며, 공급업체의 물질안전보건자료(SDS), 관련 법규 및 전문가 평가를 대체하지 않습니다.

GHS 분류

GHS Classification · 4건

Danger

H301 (100%): Toxic if swallowed [Danger Acute toxicity, oral]

P203, P261, P264, P264+P265, P270, P271, P280, P301+P316, P302+P352, P304+P340, P305+P351+P338, P318, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 2 reports by companies from 1 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

유해성 정보

Hazards SummaryEmergency treatment: Piperazine; Piperazine can cause vomiting, confusion, seizures, and coma at therapeutic levels (75 mg/kg/day) in patients with normal renal function; [HSDB] An irritant; [MP MSDS] See Piperazine and salts.
Hazard Classes and CategoriesAcute Tox. 3 (100%)

안전 및 보호

Protective Action Criteria (PAC) · 3건

0.48 [mg/m3]

5.3 [mg/m3]

32 [mg/m3]

독성 정보

Adverse EffectsNeurotoxin - Other CNS neurotoxin
Non-Human Toxicity Excerpts · 5건

CARCINOGENIC ACTIVITY OF NITROSO COMPD: 1,4-DINITROSOPIPERAZINE AFFECTED THE ESOPHAGUS, LIVER, NASAL CAVITIES, & FORESTOMACH OF RATS; IN MICE AFFECTED LUNG & LIVER. /FROM TABLE/

ADULT MICE WERE TREATED FOR 1 YR, PREGNANT MOTHERS IN 3RD TRIMESTER OF PREGNANCY, & LACTATING MOTHERS FOR 1ST 20 DAYS POSTPARTUM WITH DINITROSOPIPERAZINE. DEATHS ATTRIBUTABLE TO ACUTE TOXIC EFFECT AMOUNTED TO 15% AMONG TREATED ADULT MICE & 57% IN TRANSMATERNALLY EXPOSED MICE.

화학 및 산업

약리 정보

Metabolism/MetabolitesAFTER ADMIN OF (2,5-(14)C)-DINITROSOPIPERAZINE TO RATS TWO OF THE URINE METABOLITES WERE IDENTIFIED AS 3-HYDROXYNITROSOPYRROLIDINE & 1-NITROSOPIPERAZINONE-(3).
MeSH Pharmacological ClassificationSubstances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included.
Absorption, Distribution and ExcretionAFTER IP ADMIN OF 10 MG/69.5 MUCI PER KG (2,5-(14)C)-N,N'-DINITROSOPIPERAZINE TO RATS 1% OF RADIOACTIVITY WAS EXHALED AS (14)CO2, 1% WAS EXCRETED VIA BILE & ABOUT 40% WAS EXCRETED IN URINE.

용도 및 제조

Uses · 2건

Used as a research chemical; Not commercially produced in the US; [HSDB]

RESEARCH CHEMICAL

U.S. Exports · 2건

(1977) No Data

(1979) No Data

U.S. Imports · 2건

(1977) No Data

(1979) No Data

U.S. Production · 2건

(1977) NOT PRODUCED COMMERCIALLY IN US

(1979) NOT PRODUCED COMMERCIALLY IN US

Consumption PatternsESSENTIALLY 100% AS A RESEARCH CHEMICAL
Methods of ManufacturingREACTION OF PIPERAZINE WITH NITRITE
General Manufacturing InformationPiperazine, 1,4-dinitroso-: ACTIVE

관련 반응

0건
반응 기록 만들기

현재 필터 조건에 해당하는 반응 기록이 없습니다.

화합물 노트

불러오는 중…

이 페이지에서기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트
저장 조건
-20 °C · -20°C Freezer, Under Inert Atmosphere
용해도
클로로포름(약간 용해됨), DMSO(약간 용해됨), 메탄올(약간 용해됨)
물리적 상태
고체
산도 계수 (pKa)
-4.82 · -4.82±0.70(Predicted)
색상
흰색에서 연한 노란색
수용성
5.765 g/L · 5.765g/L(24℃)
Henry's Law Constant
1.9 · 1.9×102 mol/(m3Pa) at 25℃, Mirvish et al. (1976)
안정성
흡습성
InChI
InChI=1S/C4H8N4O2/c9-5-7-1-2-8(6-10)4-3-7/h1-4H2
InChIKey
WNSYEWGYAFFSSQ-UHFFFAOYSA-N
SMILES
N1(N=O)CCN(N=O)CC1
EPA
1 · Piperazine, 1,4-dinitroso- (140-79-4)

화학적 성질

Pale Yellow Solid

INCIDENCE OF TUMORS HIGHER IN TRANSMATERNALLY EXPOSED MICE. LATENCY TIME FOR APPEARANCE OF TUMORS IN TREATED ADULT MICE WAS SHORTER THAN IN CONTROLS.

MUTAGENIC ACTIVITY OF 7 NITROSOPIPERAZINES WAS EXAMINED IN X-LINKED RECESSIVE LETHAL ASSAY OF D MELANOGASTER. SUBSTITUTIONS WITH METHYL GROUPS @ ALL OF ALPHA-C ATOMS REDUCE OR ELIMINATE MUTAGENIC ACTIVITY OF DINITROSOPIPERAZINE.

DINITROSOPIPERAZINE & DEUTERIUM-CONTAINING ANALOGS WERE TESTED FOR REVERSION OF NONSENSE MUTATION IN TYR LOCUS OF ESCHERICHIA COLI WV 3610.

안전 데이터

tsca
TSCA listed
유해 물질 데이터
140-79-4(Hazardous Substances Data)

응용 분야

용도N,N'-Dinitrosopiperazine (DNP) induces nasopharyngeal carcinoma (NPC) and shows organ specificity to the nasopharyneal epithelium.

상·하류 제품 정보

하류 제품

1,4-디아미노피페라진수화물

공급사63 곳

天津始加生物医药科技有限公司15022261580 · [email protected]
安礼特(上海)医药科技有限公司18109805911 · [email protected]
艾吉析科技(上海)有限公司17717235263 · [email protected]
上海麦克林生化科技股份有限公司021-50706066 15221275939 · [email protected]
南京望知星医药科技有限公司18569809817 · [email protected]
Sinco Pharmachem (ShenZhen) R&D Co., Ltd.+86-18603013401 · [email protected]
济南启源生物科技有限公司18766124282; 18766124282 · [email protected]
安耐吉化学&3A(安徽泽升科技有限公司)021-58432009 400-005-6266 · [email protected]
上海柯维化学技术有限公司021-64609169 18901607656 · [email protected]
上海澜克医药科技有限公司021-52216295 lankepharma · [email protected]
山东沃德森生物科技有限公司0531-88723173 18596073690 · [email protected]
Moxin Chemicals+86-17320513646 +86-17320513646 · [email protected]
杭州云易国科生物科技有限公司18457506494 · [email protected]
成都思天德生物科技有限公司028-83243028 19136088901 · [email protected]
深圳振强药物研发有限公司0755-66853366 13670046396 · [email protected]
湖北扬信医药科技有限公司15347293736 · [email protected]
山东博洛达生物科技有限公司0531-68651502 · [email protected]
天津普西唐生物医药科技有限公司010-60605840 · [email protected]
深圳摩科生化科技有限公司18627923403 · [email protected]
武汉壹加壹生物科技有限公司027-027-16602739303 16602739303 · [email protected]
凯试(上海)科技有限公司021-50135380 · [email protected]
BOC Sciences16314854226; +8616314854226 · [email protected]
南京博济达医药科技有限公司18762407961 · [email protected]
广东翁江化学试剂有限公司0751-2815987 13927875076 · [email protected]
深圳卓越生物医药科技有限公司26050679 18318671572 · [email protected]
艾吉析科技(上海)有限公司17717235263 17717235263 · [email protected]
sgtlifesciences pvt ltd+91-8790379245 · [email protected]
陕西缔都医药化工有限公司029-029-81120477 17792793610 · [email protected]
南京科晟祥科技有限公司18252089365 · [email protected]
湖北扬信医药科技有限公司07143299675 13092790750 · [email protected]
深圳菲斯生物科技有限公司0755-4000505016 13380397412 · [email protected]
湖北摩科生物科技有限公司18274848843 · [email protected]
南雄市普强生物科技有限公司15702096460 13602449734 · [email protected]
湖北瑞诺医药科技有限公司13165688766 · [email protected]
上海康满林生物医药有限公司68080707 15021879576 · [email protected]
Shaanxi Didu New Materials Co. Ltd+86-86-17392712779 +86-13289823923 · [email protected]
广州佳途科技股份有限公司020-81960175-877 18933936954 · [email protected]
嘉兴市德亿化工有限公司86-0573-85866609 18367600069 · [email protected]
江苏艾康生物医药研发有限公司025-58859352 13913916777 · [email protected]
河南天孚化工有限公司+86-0371-55170693 +86-19937530512 · [email protected]
北京迪泰医药科技有限公司010-13810111756 13011240343 · [email protected]
深圳聚合生化科技有限公司+86-400-002-6226 13028896684 · [email protected]
广州市桐晖药业有限公司020-66392521-118 18922260391 · [email protected]
河南阿尔法化工有限公司0371-55055611 18137792234 · [email protected]
湖北摩科化学有限公司18627753421; 18627756402 · [email protected]
深圳市恒丰万达医药科技有限公司13986652530 · [email protected]
河南伊诺凯新材料有限公司15565215982 15565215982 · [email protected]
SHANGHAI KEAN TECHNOLOGY CO., LTD.+8613817748580 · [email protected]
河南伊诺凯新材料有限公司17634273666 · [email protected]
上海杰股生物科技有限公司021-51698675 · [email protected]